CARDIOVASCULAR COMPLICATIONS AND CARBOHYDRATE METABOLISM IN CORONARY SHUNTING “OFF-PUMP” ACCORDING TO THE REGIMEN OF GLUCOSE LOWERING TREATMENT IN ISCHEMIC HEART DISEASE AND DIABET...

by S. Yu. Borodashkina, V. A. Podkamenny, K. V. Protasov
Published 2016-02-01

Worldwide inertia to the use of cardiorenal protective glucose-lowering drugs (SGLT2i and GLP-1 RA) in high-risk patients with type 2 diabetes

by Guntram Schernthaner, Naim Shehadeh, Alexander S. Ametov, Anna V. Bazarova, Fahim Ebrahimi, Peter Fasching, Andrej Janež, Péter Kempler, Ilze Konrāde, Nebojša M. Lalić, Boris Mankovsky, Emil Martinka, Dario Rahelić, Cristian Serafinceanu, Jan Škrha, Tsvetalina Tankova, Žydrūnė Visockienė
Published 2020-10-01

Mediterranean Diet and Physical Activity Decrease the Initiation of Cardiovascular Drug Use in High Cardiovascular Risk Individuals: A Cohort Study

by Margarita Ribó-Coll, Sara Castro-Barquero, Camille Lassale, Emilio Sacanella, Emilio Ros, Estefanía Toledo, José V. Sorlí, Andrés Díaz-López, José Lapetra, Carlos Muñoz-Bravo, Fernando Arós, Miquel Fiol, Lluis Serra-Majem, Xavier Pinto, Olga Castañer, César I. Fernández-Lázaro, Olga Portolés, Nancy Babio, Ramón Estruch, Álvaro Hernáez
Published 2021-03-01

Hospitalization for hypoglycaemia in people with diabetes in Denmark, 1997–2017: Time trends in incidence and HbA1c and glucose‐lowering drug use before and after hypoglycaemia

by Mads Bisgaard Bengtsen, Jakob Schöllhammer Knudsen, Maria Bisgaard Bengtsen, Niels Møller, Reimar Wernich Thomsen
Published 2021-07-01

Diabetes and Aging: From Treatment Goals to Pharmacologic Therapy

by Miriam Longo, Giuseppe Bellastella, Maria Ida Maiorino, Juris J. Meier, Katherine Esposito, Dario Giugliano
Published 2019-02-01

Platelet Effects of Anti-diabetic Therapies: New Perspectives in the Management of Patients with Diabetes and Cardiovascular Disease

by Annunziata Nusca, Dario Tuccinardi, Silvia Pieralice, Sara Giannone, Myriam Carpenito, Lavinia Monte, Mikiko Watanabe, Ilaria Cavallari, Ernesto Maddaloni, Gian Paolo Ussia, Silvia Manfrini, Francesco Grigioni
Published 2021-05-01

The Impact of Glucose-Lowering Drugs on Sarcopenia in Type 2 Diabetes: Current Evidence and Underlying Mechanisms

by Elena Massimino, Anna Izzo, Gabriele Riccardi, Giuseppe Della Pepa
Published 2021-08-01

Sodium-Glucose Cotransporter-2 Inhibitors at Discharge from Cardiology Hospitalization Department: Decoding A New Clinical Scenario

by José Rozado, Daniel García Iglesias, Miguel Soroa, Alejandro Junco-Vicente, Noemí Barja, Antonio Adeba, María Vigil-Escalera, Rut Alvarez, Francisco Torres Saura, Esmeralda Capín, Laura García, María Luisa Rodriguez, David Calvo, Cesar Moris, Elías Delgado, Jesús María de la Hera
Published 2020-08-01

The Genetics of Adverse Drug Outcomes in Type 2 Diabetes: A Systematic Review

by Assefa M. Baye, Teferi G. Fanta, Moneeza K. Siddiqui, Adem Y. Dawed
Published 2021-06-01

Features of treating type 2 diabetes mellitus in the elderly

by W.A. El Zein, T.V. Mokhort
Published 2019-09-01

Assessment of channeling bias among initiators of glucose-lowering drugs: A UK cohort study

by Ankarfeldt MZ, Thorsted BL, Groenwold RHH, Adalsteinsson E, Ali MS, Klungel OH
Published 2017-01-01

A systematic literature review on the efficacy–effectiveness gap: comparison of randomized controlled trials and observational studies of glucose-lowering drugs

by Ankarfeldt MZ, Adalsteinsson E, Groenwold RHH, Ali MS, Klungel OH
Published 2017-01-01

Mortality and other adverse outcomes in patients with type 2 diabetes mellitus admitted for COVID-19 in association with glucose-lowering drugs: a nationwide cohort study

by Luis M. Pérez-Belmonte, José David Torres-Peña, María D. López-Carmona, M. Mar. Ayala-Gutiérrez, Francisco Fuentes-Jiménez, Lucía Jorge Huerta, Jaime Alonso Muñoz, Manuel Rubio-Rivas, Manel Madrazo, Marcos Guzmán Garcia, Beatriz Vicente Montes, Joaquim Fernández Sola, Javier Ena, Ruth Gonzalez Ferrer, Carmen Mella Pérez, Carlos Jorge Ripper, Jose Javier Napal Lecumberri, Iris El Attar Acedo, Susana Plaza Canteli, Sara Fuente Cosío, Francisco Amorós Martínez, Begoña Cortés Rodríguez, Pablo Pérez-Martínez, José Manuel Ramos-Rincón, Ricardo Gómez-Huelgas, for the SEMI-COVID-19 Network
Published 2020-11-01